These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3248681)

  • 1. Transition-state analogues as inhibitors of L-dopa decarboxylase.
    Brinkworth RI; Iles MM; Iskander MN; Andrews PR
    Int J Biochem; 1988; 20(11):1273-9. PubMed ID: 3248681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pig kidney dopa decarboxylase by coenzyme-5-hydroxytryptophan adducts.
    Dominici P; Curini M; Minelli A; Borri Voltattorni C
    Experientia; 1984 Aug; 40(8):834-5. PubMed ID: 6468591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme--substrate adducts as inhibitors of mouse liver 3,4-dihydroxyphenylalanine decarboxylase.
    Rudd EA; Cunningham WC; Thanassi JW
    J Med Chem; 1979 Mar; 22(3):233-7. PubMed ID: 423204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors binding to L-aromatic amino acid decarboxylase.
    Barboni E; Voltattorni CB; D'Erme M; Fiori A; Minelli A; Rosei MA
    Life Sci; 1982 Oct; 31(14):1519-24. PubMed ID: 6183555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
    Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
    Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited tryptic proteolysis of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Simmaco M; Schininà ME; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1988 Feb; 260(2):569-76. PubMed ID: 3124758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aromatic L-aminoacid decarboxylase in clonal pheochromocytoma PC12h cells by N-methyl-4-phenylpyridinium ion (MPP+).
    Naoi M; Takahashi T; Ichinose H; Nagatsu T
    Biochem Biophys Res Commun; 1988 Apr; 152(1):15-21. PubMed ID: 3258744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ
    Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract]   [Full Text] [Related]  

  • 9. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
    Bertoldi M; Borri Voltattorni C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity and other properties of DOPA decarboxylase from guinea pig kidneys.
    Srinivasan K; Awapara J
    Biochim Biophys Acta; 1978 Oct; 526(2):597-604. PubMed ID: 309771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of pig kidney L-aromatic amino acid decarboxylase by 2,3-methano-m-tyrosines.
    Ahmad S; Phillips RS; Stammer CH
    J Med Chem; 1992 Apr; 35(8):1410-7. PubMed ID: 1573634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles of the active site lysine of Dopa decarboxylase.
    Bertoldi M; Voltattorni CB
    Arch Biochem Biophys; 2009 Aug; 488(2):130-9. PubMed ID: 19580779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1985 May; 238(2):565-73. PubMed ID: 3994391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aromatic L-amino acid decarboxylase by coenzyme-amino acid adducts.
    Rudd EA; Thanassi JW
    Biochemistry; 1981 Dec; 20(26):7469-75. PubMed ID: 7326239
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors.
    Montioli R; Voltattorni CB; Bertoldi M
    Curr Drug Metab; 2016; 17(5):513-8. PubMed ID: 27025882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-binding and competitive inhibition of 8-amino-7-oxopelargonate synthase, a pyridoxal-5'-phosphate-dependent enzyme involved in biotin biosynthesis, by substrate and intermediate analogs. Kinetic and binding studies.
    Ploux O; Breyne O; Carillon S; Marquet A
    Eur J Biochem; 1999 Jan; 259(1-2):63-70. PubMed ID: 9914476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats.
    Rahman MK; Nagatsu T; Sakurai T; Hori S; Abe M; Matsuda M
    Jpn J Pharmacol; 1982 Oct; 32(5):803-11. PubMed ID: 6983619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
    Dominici P; Moore PS; Castellani S; Bertoldi M; Voltattorni CB
    Protein Sci; 1997 Sep; 6(9):2007-15. PubMed ID: 9300500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.
    Tran N
    Experientia; 1972 Sep; 28(9):1021-2. PubMed ID: 4665286
    [No Abstract]   [Full Text] [Related]  

  • 20. Affinity labeling of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active-site cysteine.
    Dominici P; Maras B; Mei G; Borri Voltattorni C
    Eur J Biochem; 1991 Oct; 201(2):393-7. PubMed ID: 1935936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.